Ptc Therapeutics (PTCT) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $15.9 million.
- Ptc Therapeutics' Consolidated Net Income rose 11490.43% to $15.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $489.4 million, marking a year-over-year increase of 19032.47%. This contributed to the annual value of -$625.6 million for FY2024, which is 1253.16% up from last year.
- Per Ptc Therapeutics' latest filing, its Consolidated Net Income stood at $15.9 million for Q3 2025, which was up 11490.43% from -$64.8 million recorded in Q2 2025.
- Ptc Therapeutics' 5-year Consolidated Net Income high stood at $866.6 million for Q1 2025, and its period low was -$328.2 million during Q4 2024.
- Moreover, its 5-year median value for Consolidated Net Income was -$128.6 million (2021), whereas its average is -$84.7 million.
- Per our database at Business Quant, Ptc Therapeutics' Consolidated Net Income tumbled by 9173.51% in 2021 and then soared by 104627.63% in 2025.
- Ptc Therapeutics' Consolidated Net Income (Quarter) stood at -$143.3 million in 2021, then fell by 21.82% to -$174.5 million in 2022, then crashed by 40.05% to -$244.4 million in 2023, then tumbled by 34.27% to -$328.2 million in 2024, then soared by 104.84% to $15.9 million in 2025.
- Its last three reported values are $15.9 million in Q3 2025, -$64.8 million for Q2 2025, and $866.6 million during Q1 2025.